AN

Anu Nayyar

Active Director Director DIN 07779363
DIN 07779363 First appointment Mar 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Anu Nayyar

Data last updated:

Anu Nayyar is a Director at Sidhaant Life Sciences Private Limited (since 2017). The company operates in Pharma. Sidhaant Life Sciences Private Limited reported revenue of ₹146 Cr (FY 2025).

DIN 07779363
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2017
Oldest Company Age 22 yrs
Largest company Sidhaant Life Sciences Private Limited · ₹146 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20172004₹146 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Sidhaant Life Sciences Private Limited
Premium access

Shareholding and investment profile for Anu Nayyar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anu Nayyar

Anu Nayyar currently holds 1 directorship: Sidhaant Life Sciences Private Limited (Director, since 31 Mar 2017, revenue ₹146 Cr (FY 2025)).

Anu Nayyar was first appointed on 31 Mar 2017 as Director at Sidhaant Life Sciences Private Limited.

The current boards of Anu Nayyar's companies include Jetender Sabharwal (Sidhaant Life Sciences Private Limited), Sidhaant Sabharwal (Sidhaant Life Sciences Private Limited), Sudarshan Sabharwal (Sidhaant Life Sciences Private Limited), Sulabh Nayyar (Sidhaant Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available